Finance
Revance Therapeutics Inc [RVNC] stock Downgrade by Mizuho analyst, price target now $9
Revance Therapeutics Inc [NASDAQ: RVNC] traded at a low on Thursday, posting a -0.27 loss after which it closed the day’ session at $3.63. The results of the trading session contributed to over 8171681 shares changing hands. Over the past one week, the price volatility
